Categories: News

Buyback of Class B shares in Essity during week 44, 2024

STOCKHOLM, Nov. 4, 2024 /PRNewswire/ — Between October 28, 2024, and November 1, 2024, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.

The share purchase is part of the SEK 3bn buyback program announced by Essity on June 17, 2024. The buyback program will extend from June 17, 2024, until the 2025 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission’s Delegated Regulation 2016/1052 (Safe Harbour Regulation).

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity’s capital allocation.

Class B shares in Essity were repurchased as follows:

Date

Aggregated daily volume (no. of shares):

Weighted average price per day (SEK):

Total daily transaction value (SEK):

October 28, 2024

54,000

310.2743

16,754,812

October 29, 2024

54,000

309.1655

16,694,937

October 30, 2024

54,000

303.4483

16,386,208

October 31, 2024

54,000

299.4882

16,172,363

November 1, 2024

54,000

303.0732

16,365,953

Total accumulated during week 44, 2024

270,000

305.0899

82,374,273

Total accumulated during the buyback program

5,346,000

301.0931

1,609,643,586

All purchases were conducted on Nasdaq Stockholm by Danske Bank on behalf of Essity. Following the above purchases, Essity’s holding of treasury shares amounted on November 1, 2024, to 5,346,000 Class B shares. The total number of shares in Essity amounted on the date of this press release to 702,342,489, of which 60,412,986 Class A shares and 641,929,503 Class B shares. 

The full details concerning the completed transactions are appended to this press release.

For further information, please contact:
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/essity/r/buyback-of-class-b-shares-in-essity-during-week-44–2024,c4060680

The following files are available for download:

https://mb.cision.com/Main/15798/4060680/3092536.pdf

Buyback of Class B shares in Essity during week 44, 2024

https://mb.cision.com/Public/15798/4060680/b174f500b6bab21d.pdf

Essity transactions week 44

 

View original content:https://www.prnewswire.com/news-releases/buyback-of-class-b-shares-in-essity-during-week-44-2024-302295251.html

SOURCE Essity

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

17 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

17 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago